JPMorgan Claverhouse (LON:JCH – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 713.68 ($8.71) and traded as low as GBX 697.45 ($8.52). JPMorgan Claverhouse shares last traded at GBX 706 ($8.62), with a volume of 52,442 shares changing hands.
JPMorgan Claverhouse Trading Down 1.4 %
The company has a current ratio of 0.71, a quick ratio of 67.67 and a debt-to-equity ratio of 11.85. The stock has a market capitalization of £396.51 million, a P/E ratio of 675.73 and a beta of 0.83. The company has a 50-day moving average price of GBX 701.42 and a 200 day moving average price of GBX 713.68.
JPMorgan Claverhouse Announces Dividend
The company also recently announced a dividend, which was paid on Wednesday, December 4th. Shareholders of record on Thursday, November 7th were issued a GBX 8.25 ($0.10) dividend. The ex-dividend date of this dividend was Thursday, November 7th. This represents a yield of 1.15%. JPMorgan Claverhouse’s dividend payout ratio is presently 3,398.06%.
JPMorgan Claverhouse Company Profile
JPMorgan Claverhouse Investment Trust plc is a closed ended equity mutual fund launched and managed by JPMorgan Funds Limited. It is co-managed by JPMorgan Asset Management (UK) Limited. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in stocks of companies operating across diversified sectors.
Featured Stories
- Five stocks we like better than JPMorgan Claverhouse
- Where to Find Earnings Call Transcripts
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Overbought Stocks Explained: Should You Trade Them?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for JPMorgan Claverhouse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Claverhouse and related companies with MarketBeat.com's FREE daily email newsletter.